205 related articles for article (PubMed ID: 32484406)
1. Outpatient parenteral antibiotic therapy for the treatment of prosthetic knee and hip infections in Belgium, a cost minimization analysis.
Debaenst N; Seyler L; Putman K; Van Den Borre I; Vanlauwe J
Acta Clin Belg; 2022 Feb; 77(1):10-17. PubMed ID: 32484406
[TBL] [Abstract][Full Text] [Related]
2. [Cost analysis of inpatient versus outpatient intravenous antibiotic treatment for periprosthetic joint infections : A simulation].
Boese CK; Lechler P; Frink M; Hackl M; Eysel P; Ries C
Orthopade; 2021 Feb; 50(2):150-158. PubMed ID: 32076752
[TBL] [Abstract][Full Text] [Related]
3. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM
Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
[TBL] [Abstract][Full Text] [Related]
5. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
Dimitrova M; Gilchrist M; Seaton RA
BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
[TBL] [Abstract][Full Text] [Related]
6. Implementation of Outpatient Parenteral Antimicrobial Therapy (OPAT) in Patients with Complicated Periprosthetic Joint Infections.
Strassburg A; Weber AT; Kluba T
Z Orthop Unfall; 2024 May; ():. PubMed ID: 38802072
[TBL] [Abstract][Full Text] [Related]
7. Outpatient parenteral antibiotic therapy (OPAT) and inpatient treatment strategies for emergency department patients with cellulitis: a cost analysis.
Yadav K; Kumar S; Chhabra S; Rosenberg H; Eagles D; Suh KN; Ohle R; Nath A; Thavorn K
CJEM; 2022 Aug; 24(5):520-528. PubMed ID: 35675027
[TBL] [Abstract][Full Text] [Related]
8. [A practical program for outpatient parenteral antimicrobial therapy].
Ravelingien T; Buyle F; Deryckere S; Huis In 't Veld D; Debrauwere M; Verplancke K; Callens S; Commeyne S; Pattyn C; Somers A; Vogelaers D
J Pharm Belg; 2016 Sep; (3):22-31. PubMed ID: 30281241
[TBL] [Abstract][Full Text] [Related]
9. Cost minimization analysis of outpatient parenteral/oral antibiotic therapy at a trauma hospital: Public health system.
Loesch GH; Cruz JAW; Gasparetto J; Oliveira DDS; Telles JP; Tuon FF
Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1445-1450. PubMed ID: 33618784
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
[TBL] [Abstract][Full Text] [Related]
11. OPAT: proof of concept in a peripheral Belgian hospital after review of the literature.
Smismans A; Vantrappen A; Verbiest F; Indevuyst C; Van den Poel B; von Winckelmann S; Peeters A; Ombelet S; Lybeert P; Heremans A; Frans E; Ho E; Frans J
Acta Clin Belg; 2018 Aug; 73(4):257-267. PubMed ID: 29385901
[TBL] [Abstract][Full Text] [Related]
12. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.
Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD
BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
[TBL] [Abstract][Full Text] [Related]
14. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
[TBL] [Abstract][Full Text] [Related]
15. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
[TBL] [Abstract][Full Text] [Related]
16. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
Chan M; Ooi CK; Wong J; Zhong L; Lye D
BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
[TBL] [Abstract][Full Text] [Related]
18. A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy.
Kutubi A; O'Brien L; Murphy B; Fitzpatrick P; Hurson C; Rajendran D; Feeney E; Mallon P; Waqas S
Heliyon; 2023 Apr; 9(4):e15212. PubMed ID: 37113779
[TBL] [Abstract][Full Text] [Related]
19. A cost minimisation analysis comparing oral linezolid and intravenous daptomycin administered via an outpatient parenteral antibiotic therapy programme in patients requiring prolonged antibiotic courses.
Faller E; Jackson A
J Chemother; 2023 Sep; 35(5):411-424. PubMed ID: 36398996
[TBL] [Abstract][Full Text] [Related]
20. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
